logo


Harmonized System Codes • Schedule B • Harmonized Commodity Description

Searched for: hiv drugs

Aromatic amino-alcohols drugs, their ethers and esters, other than those containing > one kind of oxygen function; salts thereof; nesoi
Drugs of amino-naphthols and -phenols, their ethers and esters, except those cont. more than one oxygen function; salts thereof, nesoi
Aromatic amino-acids drugs and their esters, not containing more than one kind of oxygen function, nesoi
Aromatic drugs of imines and their derivatives, nesoi
Aromatic imines and their derivatives; salts thereof (excluding drugs); nesoi
Isoetharine hydrochloride and other specified aromatic drugs of amino-compounds with oxygen function
Other aromatic cardiovascular drugs of amino-compounds with oxygen function
Aromatic drugs of amino-compounds with oxygen function, nesoi
Other aromatic cyclic amides and derivatives for use as drugs
Aromatic drugs of lactones
Other aromatic or modified aromatic drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure
Nonaromatic drugs of organic derivatives of hydrazine or of hydroxylamine, other than Methyl ethyl ketoxime
Drugs of aromatic organo-inorganic (except organo-sulfur) compounds
Aromatic or modified aromatic drugs of heterocyclic compounds with nitrogen hetero-atom(s) only containing an unfused pyrazole ring
Nonaromatic drugs of heterocyclic compounds with nitrogen hetero-atom(s) only containing an unfused pyrazole ring
Other compound (excluding aromatic, modified aromatic & drugs) containing unfused pyrazole ring (whether or n/hydrogenated) in the structure
Aromatic or modified aromatic drugs of heterocyclic compounds with nitrogen hetero-atom(s) only cont. an unfused imidazole ring
Nonaromatic drugs of heterocyclic compounds with nitrogen hetero-atom(s) only, containing an unfused imidazole ring, nesoi
Other compounds (excluding drugs, aromatic and modified aromatic compounds) containing an unfused imidazole ring (whether or n/hydrogenated)
Drugs containing an unfused pyridine ring (whether or not hydrogenated) in the structure, nesoi
Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoi
Drugs of quinones
Aromatic or modified aromatic cardiovascular drugs of heterocyclic compounds with nitrogen hetero-atom(s) only, nesoi
Aromatic or modified aromatic drugs affecting the central nervous system, of heterocyclic compounds with nitrogen atom(s) only, nesoi
Aromatic or modified aromatic drugs of heterocyclic compounds with nitrogen hetero-atom(s) only, nesoi
Nonaromatic drugs of heterocyclic compounds with nitrogen hetero-atom(s) only, nesoi
Other drugs containing a phenothiazine ring system (whether or not hydrogenated), not further fused, nesoi
Aromatic or modified aromatic drugs of other heterocyclic compounds, nesoi
Nonaromatic drugs of other heterocyclic compounds, nesoi
Other sulfonamide drugs (excluding anti-infective agents)
Other sulfonamides (excluding drugs and certain specified chemicals) described in additional U.S. note 3 to section VI
Other sulfonamides (excluding drugs and certain specified chemicals) not described in additional U.S. note 3 to section VI
Aromatic or modified aromatic drugs of other organic compounds, nesoi
Aromatic monoamine drugs, nesoi
Aromatic drugs derived from carboxylic acids with additional oxygen function, and their derivatives, nesoi
Nonaromatic drugs of heterocyclic compounds nesoi, with nitrogen hetero-atom(s) only, cont. a pyrimidine or piperazine ring
We use cookies and 3rd party services to recognize visitors, target ads and analyze site traffic.
By using this site you agree to this Privacy Policy. Learn how to clear cookies here